PG110, A Humanized Anti-NGF Antibody, Reverses Established Pain Hypersensitivity in Persistent Inflammatory Pain, but not Peripheral Neuropathic Pain, Rat Models.
about
Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis painNerve growth factor: a neuroimmune crosstalk mediator for all seasons.Nociceptor plasticity: A closer look.The TrkA receptor mediates experimental thermal hyperalgesia produced by nerve growth factor: Modulation by the p75 neurotrophin receptor.Neurotrophic Factors: An Overview.Blocking of cytokines signalling attenuates evoked and spontaneous neuropathic pain behaviours in the paclitaxel rat model of chemotherapy-induced neuropathy.
P2860
PG110, A Humanized Anti-NGF Antibody, Reverses Established Pain Hypersensitivity in Persistent Inflammatory Pain, but not Peripheral Neuropathic Pain, Rat Models.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PG110, A Humanized Anti-NGF An ...... Neuropathic Pain, Rat Models.
@en
PG110, A Humanized Anti-NGF An ...... Neuropathic Pain, Rat Models.
@nl
type
label
PG110, A Humanized Anti-NGF An ...... Neuropathic Pain, Rat Models.
@en
PG110, A Humanized Anti-NGF An ...... Neuropathic Pain, Rat Models.
@nl
prefLabel
PG110, A Humanized Anti-NGF An ...... Neuropathic Pain, Rat Models.
@en
PG110, A Humanized Anti-NGF An ...... Neuropathic Pain, Rat Models.
@nl
P2860
P356
P1433
P1476
PG110, A Humanized Anti-NGF An ...... Neuropathic Pain, Rat Models.
@en
P2093
Laiche Djouhri
P2860
P304
P356
10.1093/PM/PNW007
P577
2016-02-25T00:00:00Z